Seeking Alpha

arthurs1

arthurs1
Send Message
View as an RSS Feed
View arthurs1's Comments BY TICKER:
Latest  |  Highest rated
  • Isis - Addressing Some Of The Bull Arguments To My Short Thesis [View article]
    Videos don't lie. One of many children improving with SMNrx.
    http://bit.ly/TVNL8e
    Jul 10 06:33 PM | Likes Like |Link to Comment
  • Isis - Addressing Some Of The Bull Arguments To My Short Thesis [View article]
    The complete fools at GSK just decided to continue to pay ISIS again to develop the HBV drug. Ever hear of the stat 3 drug? Nothing is guaranteed, but it just adds to the overwhelming evidence that BP believes the risk is worth the potential rewards.
    In June it was Biogen to develop a 4th drug. Obviously, that contradicts your whole short thesis ( as does just about everything else).
    But they aren't short stock or long puts.
    Jul 2 12:11 PM | 2 Likes Like |Link to Comment
  • Isis: Long-Term Kynamro Adverse Events May Apply To Entire ISIS 2.0 Pipeline [View article]
    I believe SA should moderate what they allow to be published under their banner in particular a so called SA Pro where only a select group gets to know that a very slanted article is coming out that will increase the odds of a short term move up or down. I believe the SEC may want to look into this as well as the AGs. If you pay us you get to know that a baseless, inaccurate, article will be going public before it goes public,that says the company is probably going to beceome worthless? I think that runs afoul of SEC regs and more than one.
    Jun 27 12:21 AM | 8 Likes Like |Link to Comment
  • Isis Pharma -5.7% after negative Seeking Alpha article [View news story]
    The article is baseless and the volume AH is puny. See my comments on original article.
    Jun 26 08:00 PM | 2 Likes Like |Link to Comment
  • Isis: Long-Term Kynamro Adverse Events May Apply To Entire ISIS 2.0 Pipeline [View article]
    I'm not so sure ISIS should respond to every baseless short promotion on SA. Those individuals who would sell on this tripe probably should not be in the stock. They know nothing It's probably more short selling AH than anything else. There was imo a lot of shorting when this came out the past couple of days. Now they will be looking to cover with it going public.
    SA needs to decide if it wants to continue selling it's soul to the devil or become legitimate.
    Jun 26 07:44 PM | 2 Likes Like |Link to Comment
  • Isis: Long-Term Kynamro Adverse Events May Apply To Entire ISIS 2.0 Pipeline [View article]
    There's very little volume. Individual shareholders including shorts.
    Jun 26 07:37 PM | 1 Like Like |Link to Comment
  • Isis: Long-Term Kynamro Adverse Events May Apply To Entire ISIS 2.0 Pipeline [View article]
    So that must be why Kynamro sales keep growing. It's not working? What about 2.2 gen drugs (the majority) and 2.5 gen?
    How do you extrapolate this 2.0 drug to those much improved drugs that have a much better immunological profile and are far more powerful.
    Jun 26 04:35 PM | 8 Likes Like |Link to Comment
  • Isis: Long-Term Kynamro Adverse Events May Apply To Entire ISIS 2.0 Pipeline [View article]
    This is junk science. Isis is up over 10 points since the previously posted SA junk science piece. The newer drugs have no flu like symptoms at least from what I've read and few and mild infrequent ivrs.
    Kynamo is a comparatively old drug and a not very important drug, but dropouts have gone down, their is a huge trial that will finish next year, a scientific journal recently reported that it may be a valuable drug for those with very high ldl-c, and almost every other athrogenic lipid. During the original trial they had to stick the patient in the same spot all the time. There are no Hy's Law infractions. It has not damaged livers.
    Every partner continues to pay milestones for every drug and they keep partnering for new drugs.
    You are in a time warp. I felt like I was reading something from 3 years ago. How in the world do you qualify for SA pro when you have 2 followers??? After reading this I would never subscribe to SA Pro.
    Jun 26 04:12 PM | 27 Likes Like |Link to Comment
  • Buy Prospect Capital After The SEC's All-Clear [View article]
    First we kill the (tort) lawyers!
    The same blood suckers lined up to shake down ISIS when the stock tanked a couple years ago on unfounded rumors putting further pressure on the stock. When the stock rebounded strongly in the following 3- 4 months the lawyers disappeared for good.
    Facts are of no consequence to those with a license to steal.
    Jun 10 07:58 PM | 5 Likes Like |Link to Comment
  • Success Of Rexahn's Nano-Sized Taxotere Can Help Big Pharma Ease Patent Cliff [View article]
    See SRPT. Soared after reverse split. If it a stock goes up $10 after a rs it would have only gone up 1 before. The mv is the same, and though more stocks go down after a rs, it because of company issues and not the rs. Companies that do a rs more often than not are developmental and had been trending down or stuck at a very low price.
    It's one of those what came first the chicken or the egg?
    Apr 23 01:33 PM | Likes Like |Link to Comment
  • PTC Therapeutics Looks Like A High-Risk Play On Rare Diseases [View article]
    The father of one patient on the ISIS drug has a blog. He has reported outstanding improvement in his daughter in multiple areas. He is so happy she is now getting the higher 12 mg dose. New data will be reported on April 26. Stay tuned and God bless these children.
    Apr 12 04:47 PM | 1 Like Like |Link to Comment
  • Idera slumps [View news story]
    Pran's results can at best be labeled mixed. Overall little or no improvement. One category out of 8 showed improvement.
    Mar 24 11:33 PM | Likes Like |Link to Comment
  • Galena Biopharma, Inc. EPS of -$0.46 [View news story]
    Have you ever heard of an unofficial SEC investigation?
    It's kind of like being a little bit pregnant.
    Mar 17 09:47 PM | 3 Likes Like |Link to Comment
  • Galena Biopharma, Inc. EPS of -$0.46 [View news story]
    Smack down!
    Mar 17 09:45 PM | 3 Likes Like |Link to Comment
  • Tekmira Announces Proposed Public Offering of Common Stock [View article]
    Not wasting any time selling into the froth. Must be counting their lucky stars.
    Mar 10 06:51 PM | Likes Like |Link to Comment
COMMENTS STATS
343 Comments
327 Likes